(Q43689110)

25 November 2017

Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production (English)

1 reference

25 November 2017

0 references

Price JM

1

1 reference

25 November 2017

Chi X

series ordinal

2

1 reference

25 November 2017

Hellermann G

series ordinal

3

1 reference

25 November 2017

Sutton ET

series ordinal

4

1 reference

25 November 2017

language of work or name

1 reference

1 July 2001

1 reference

25 November 2017

Neurological Research

1 reference

25 November 2017

23

1 reference

25 November 2017

5

1 reference

25 November 2017

506-512

1 reference

A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease

25 November 2017

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Blood-brain barrier transport of circulating Alzheimer's amyloid beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Amyloid beta peptide enhanced bradykinin-mediated inositol (1,4,5)trisphosphate formation and cytosolic free calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Amyloid-beta-protein isoforms in brain of subjects with PS1-linked, beta APP-linked and sporadic Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Cerebrovascular muscle atrophy is a feature of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Potassium channel openers prevent beta-amyloid toxicity in bovine vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198758

10.1179/016164101101198758

21 January 2018

Identifiers

DOI

1 reference

release_v2pzw4mgyvgadcff2l3wu67vta

25 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v2pzw4mgyvgadcff2l3wu67vta

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference